In fact, VE-cadherin gene expression and immunohistochemical staining was evaluated in canine myxomatous mitral valve disease to investigate the role of EMT in chronic valvulopathies, showing a significant cdh5 gene dysregulation (72). The gene discussed is CDH5; the disease is mitral valve disorder.